Troyen A. Brennan net worth and biography

Troyen Brennan Biography and Net Worth

EVP of CVS Health

Troyen Brennan, M.D., M.P.H., is the chief medical officer and executive vice president for CVS Health. In these roles, he provides oversight for the development of the company’s clinical and medical affairs and health care strategy.

He also serves on the boards of Dartmouth-Hitchcock Medical Center and LumiraDx Ltd., and as a member of the Institute of Medicine of the National Academy of Sciences.

Previously, he held the position of president and CEO of The Brigham & Women's Hospital, Inc., chief medical officer and EVP at Aetna, Inc., and president and CEO for Brigham & Women’s Physicians Organization, Inc. Dr. Brennan has also served on the faculties of Harvard Medical School, Harvard Law School and the Harvard School of Public Health.

Dr. Brennan holds an undergraduate degree from Southern Methodist University, and graduate degrees from Yale Law School, Yale School of Medicine and the University of Oxford.

What is Troyen A. Brennan's net worth?: The estimated net worth of Troyen A. Brennan is at least $6.22 million as of September 2nd, 2021. Dr. Brennan owns 140,201 shares of CVS Health stock worth more than $6,219,316 as of December 21st. This net worth estimate does not reflect any other investments that Dr. Brennan may own. Learn More about Troyen A. Brennan's net worth.
How do I contact Troyen A. Brennan?: The corporate mailing address for Dr. Brennan and other CVS Health executives is ONE CVS DR., WOONSOCKET RI, 02895. CVS Health can also be reached via phone at (401) 765-1500 and via email at [email protected]. Learn More on Troyen A. Brennan's contact information.
Has Troyen A. Brennan been buying or selling shares of CVS Health?: Troyen A. Brennan has not been actively trading shares of CVS Health in the last ninety days. Most recently, Troyen A. Brennan sold 47,937 shares of the business's stock in a transaction on Thursday, February 3rd. The shares were sold at an average price of $110.00, for a transaction totalling $5,273,070.00. Learn More on Troyen A. Brennan's trading history.
Who are CVS Health's active insiders?: CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Jonathan Roberts (COO), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?: In the last twelve months, CVS Health insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $53,880.00. In the last twelve months, insiders at the pharmacy operator sold shares 1 times. They sold a total of 29,473 shares worth more than $2,267,947.35. The most recent insider tranaction occured on May, 2nd when Director Edward J Ludwig bought 1,000 shares worth more than $53,880.00. Insiders at CVS Health own 0.2% of the company. Learn More about insider trades at CVS Health.
Information on this page was last updated on 5/2/2024.

Troyen A. Brennan Insider Trading History at CVS Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/3/2022	Sell	47,937	$110.00	$5,273,070.00
11/1/2021	Sell	28,159	$90.00	$2,534,310.00
10/26/2021	Sell	82,757	$88.00	$7,282,616.00
9/2/2021	Sell	2,625	$87.00	$228,375.00	140,201
6/15/2021	Sell	67,552	$86.00	$5,809,472.00	210,378
5/7/2021	Sell	9,477	$84.00	$796,068.00	144,697
11/4/2019	Sell	23,604	$68.00	$1,605,072.00	107,921
11/14/2018	Sell	14,229	$82.00	$1,166,778.00
3/21/2017	Sell	23,849	$78.73	$1,877,631.77	94,309
5/5/2016	Sell	7,517	$105.00	$789,285.00	69,601
10/27/2015	Sell	23,603	$105.00	$2,478,315.00	43,858
4/2/2015	Sell	33,384	$102.48	$3,421,192.32
3/23/2015	Sell	33,274	$104.94	$3,491,773.56

Troyen A. Brennan Buying and Selling Activity at CVS Health

CVS Health Company Overview

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Today's Range

Now: $44.36

$43.68

$44.77

50 Day Range

MA: $56.24

$43.78

$67.46

2 Week Range

Now: $44.36

$43.60

$83.25

Volume

21,082,219 shs

Average Volume

11,653,444 shs

Market Capitalization

$55.82 billion

P/E Ratio

11.26

Dividend Yield

5.71%

Beta

0.54

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.